Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Weight Management in Adults With Overweight or Obesity (China cohort of SURMOUNT-1)
CTR20200672Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in obesity, Overweight, sponsored by Eli Lilly and Company. Started Apr 2020; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20200672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200672.